ORIGINAL RESEARCH
Published on 05 Jun 2025
Anticancer activity of RM-3-22: a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo
doi 10.3389/fphar.2025.1544666
- 784 views
1,883
Total downloads
9,135
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
ORIGINAL RESEARCH
Published on 05 Jun 2025
ORIGINAL RESEARCH
Published on 22 May 2025
ORIGINAL RESEARCH
Accepted on 19 May 2025
REVIEW
Published on 15 May 2025
REVIEW
Published on 14 May 2025
ORIGINAL RESEARCH
Published on 09 Jan 2025
REVIEW
Published on 07 Jun 2024
REVIEW
Published on 28 Feb 2024
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: